Priston Pharmaceutical Private Limited
About Priston Pharmaceutical Private Limited
Data last updated:
Priston Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC366384.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹25,000. It is led by directors Arvind Kumar and Arun Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at J – 1/143 Second Floor Dda Flats Kalkaji Near Dda Park, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.35 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹60,918 (net margin -7.3%) and EBITDA of -₹60,918 (EBITDA margin -7.3%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressJ – 1/143 Second Floor Dda Flats Kalkaji Near Dda Park, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Priston Pharmaceutical Private Limited
The main business activity of Priston Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Priston Pharmaceutical Private Limited FY 2025 filings available
Priston Pharmaceutical Private Limited reported revenue of ₹8.35 Lakh (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Priston Pharmaceutical Private Limited
Revenue rose 30% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 21%. EBITDA fell 488% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Priston Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹60,918 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹60,918 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Priston Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Priston Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Priston Pharmaceutical Private Limited
Priston Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avk Filtration Private Limited | ₹8.39 Lakh (FY 2024) | •••• | •••• | •••• | Gharunda, Haryana, India | |
| Singaji Krushi Vikas Farmer Producer Company Limited | ₹8.37 Lakh (FY 2025) | •••• | •••• | 171.0% | •••• | Punasa, Madhya Pradesh, India |
| Sigma Visuals Private Limited | ₹8.36 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Delhi, India |
| Mandric Biocare Private Limited | ₹8.35 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Coxae Biointegrated Systems Private Limited | ₹8.35 Lakh (FY 2025) | •••• | •••• | 12089.0% | •••• | Bangalore, Karnataka, India |
| Priston Pharmaceutical Private Limited this company | ₹8.35 Lakh (FY 2025) | •••• | •••• | 30.0% | •••• | New Delhi, Delhi, India |
| S M Refrigeration Private Limited | ₹8.34 Lakh (FY 2024) | •••• | •••• | -84.0% | •••• | New Delhi, Delhi, India |
| Casilica DH Private Limited | ₹8.34 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Solar Paints Pvt Ltd | ₹8.34 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | Kolkata, West Bengal, India |
| Seltzer Appliances Private Limited | ₹8.34 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Varn Tools Private Limited | ₹8.3 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Priston Pharmaceutical by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Priston Pharmaceutical Private Limited
Priston Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar | Director | 18 Jul 2020 | 6 Years 2 Months | Current |
| Arun Kumar Gupta | Director | 18 Jul 2020 | 6 Years 2 Months | Current |
Charges & Borrowings of Priston Pharmaceutical Private Limited
Priston Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Priston Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Priston Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Priston Pharmaceutical Private Limited
Priston Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Arun Kumar Gupta was appointed as Director on 18 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Priston Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Priston Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Priston Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Priston Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Priston Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priston Pharmaceutical Private Limited
Priston Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 July 2020 (6+ years old) and is registered under CIN U24304DL2020PTC366384.
Priston Pharmaceutical reported revenue of ₹8.35 Lakh for FY 2025 (up 30% YoY).
Priston Pharmaceutical has 2 current directors:
- Arvind Kumar - Director
- Arun Kumar Gupta - Director
Priston Pharmaceutical reported a net loss of ₹60,918 (net margin -7.3%) and EBITDA of -₹60,918 (EBITDA margin -7.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Priston Pharmaceutical is -21% over three years. In the latest year (FY 2025) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Priston Pharmaceutical is U24304DL2020PTC366384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Priston Pharmaceutical was incorporated on 18 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Priston Pharmaceutical by revenue are Avk Filtration Private Limited, Singaji Krushi Vikas Farmer Producer Company Limited, Sigma Visuals Private Limited, Mandric Biocare Private Limited, Coxae Biointegrated Systems Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Arun Kumar Gupta was appointed as Director on 18 Jul 2020. Arvind Kumar was appointed as Director on 18 Jul 2020.
Yes, Priston Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Priston Pharmaceutical is at J – 1143 Second Floor Dda Flats Kalkaji Near Dda Park, New Delhi, Delhi, India – 110019.